-
8/18/2019 K49 - Retina
1/38
!"#$%&()*+,+- !./01 2341+546
7+89:2(; $3*+4+5 (+4+;= ?%2@"A : !2?A (+BC656 263D+BE6
-
8/18/2019 K49 - Retina
2/38
!"#$%&
• F+G+.+5 H3,83. ,+D).+ LMN
Q9 !3K56G+KI -.+83KD+O *.G3B435>.O GB3,+4)B LMN
R9 =6B.6B3K5.K> LJN
-
8/18/2019 K49 - Retina
3/38
F@!H?2 S$#!"@?2
! T"77 7$=" ;7?$A
! &2"7?7&!
! QUR ,7
-
8/18/2019 K49 - Retina
4/38
!"#$%&!
#B+5>G+B+5O KG.>! &543B.6B B.,：6B+
>3BB+4+
! ,+V)43B.6B G6
-
8/18/2019 K49 - Retina
5/38
-
8/18/2019 K49 - Retina
6/38
-
8/18/2019 K49 - Retina
7/38
=Z@!@$A
!
A. 8+[+* B3K5+!
=+1+ W+>+
! \3BG.C,35" +8>6B8>. V+*+1+
-
8/18/2019 K49 - Retina
8/38
ORA SERRATA
• The Boundary
Between the Retina
and the Ciliary Body
-
8/18/2019 K49 - Retina
9/38
7+G.>+5 !3K5+
-
8/18/2019 K49 - Retina
10/38
;?%T2$ !H"
J9
(35C)B+5C. !"#$%&%' )*+,$ LDB5 >33 D3
D6B.6D+G.6B. B3K5+ L] -)..'/&%01#2#&&*%& N
R9 ;+C6>.4 >3< /646B3>3G46B
^9 A3G6>.4 W.4+,.5 &
-
8/18/2019 K49 - Retina
11/38
;646B3>3G46BL ] >35>6B. 53)B+< B3K5+ N
;)5C>.I
• ,35C)8+* V+*+1+ ,35E+-. .,G) >+B+/
L]/6464B+5>-)D>.N
(+V+,I
•
23< =3B)V)4 LD65)>N – !"#$#%&' )*+*#,O
1+.4) ,3.4+> K5CC. -+5 G35C354B+<
• 23< \+4+5C L8+>. B35-+*O K-+D -+G+4 ,3
-
8/18/2019 K49 - Retina
12/38
S+>D)+>. B3K5+
• 7+G.>+5 /646B3>3G46BI
5)4B.>. -+B. !"#$"!%&$'(#
L!)"#"$*N• \+C.+5
-
8/18/2019 K49 - Retina
13/38
T+,8+B+5 ;)5-)> %6B,+<
L ] /)5-)>D6G. N
• H+G.< %9$$
• & _ S B3K5+ >354B+<
•
(+D)
-
8/18/2019 K49 - Retina
14/38
&8.6 !3K5+L] &%01#) '%$#",3%1$ N
•
73G+>51+ 53)B6>35>6B. B3K5+ -+B. +5 !H"1+5C -.+D.8+4D+5
+-+51+ V+.B+5 >)8B3K5+L]>)8B3K5+< `).-:2!;N
• (+V+,I –
"D>)-+K/+• "/)>. ?W3+< LDB5 .5`+,+>. +4+)
.5/3D>.N• #3B+G. I )5-3B3+>3
– !3C,+46C35
•
4%01#) 2&%#5 O $%#&• #3B+G. I 6")%) -7"5)*1+O
S.4B3D46,. G+B> G.65+<
• 8&.)*9%:% ;4
•
#3B+G. I S.4B3D46,. G+B> G
-
8/18/2019 K49 - Retina
15/38
Rhegmatogen RD
-
8/18/2019 K49 - Retina
16/38
Tractional RD
Exudative RD
-
8/18/2019 K49 - Retina
17/38
H351+D.4 S+>D)
-
8/18/2019 K49 - Retina
18/38
!3K56G+K A.+83KD+
•
Z.G3BC
-
8/18/2019 K49 - Retina
19/38
!3K56G+K A.+83KD+
•
#3B+G. I – =35-+
-
8/18/2019 K49 - Retina
20/38
PDR
NPDR
-
8/18/2019 K49 - Retina
21/38
!3K56G+K Z.G3B435>.
•
A3a5.>. bZ@
– 2.>4646N f +D.8+4 C+5CC)+5
4B+5>G6B4+g6G,.D
– G3B-+B+*+5 .54B+B3K5+
-
8/18/2019 K49 - Retina
22/38
!3K56G+K Z.G3B435>.
4"*$5(* 67)($( 8'%//$57%-".
– TB+-3 Y %6 V*+5C3>
– TB+-3 J (.5.,+< +B43B.6 +B43B.6
+5-:6B3g)-+43
–
TB+-3 Q TB+-3 P h >[6
-
8/18/2019 K49 - Retina
23/38
•
H35C3
-
8/18/2019 K49 - Retina
24/38
Grade III
Grade IV
-
8/18/2019 K49 - Retina
25/38
F!&@
-
8/18/2019 K49 - Retina
26/38
\!&@
-
8/18/2019 K49 - Retina
27/38
F!S@
-
8/18/2019 K49 - Retina
28/38
\!S@
-
8/18/2019 K49 - Retina
29/38
&!(AL&C3 !3 43B>3B.5C G- G>5)>.+ c RY 4+*)5 -.
53C983BD3,8+5C
! Gejala
! #+*+G +[+<! #+E+, G35C354B+< ,35)B)5I
D+8)B:
-.>46B>. L8354)D 835-+:C+B.> 4+,G+D83BC3
-
8/18/2019 K49 - Retina
30/38
AB1 &!(A
•
AB1 &!(A LdYiN –
AB)>35 L-3G6>.4 83B)G+ -38B.> 83B[+B5+D3D)5.5C+5
-. B3K5+N
– &4B6aD
•
H35C3.5+B 83B
-
8/18/2019 K49 - Retina
31/38
b34 &!(A
•
b34 &!(A LJYiN" GB6CB3>./ –
@,.&.*'#) 1%.:#!"7)#&*A#0.1
• H35C3
-
8/18/2019 K49 - Retina
32/38
Dry ARMD
Wet ARMD
-
8/18/2019 K49 - Retina
33/38
$5/3VK65 : $5`+,,+K65
•
F*6B.6B3K5.K> 46g6G,+ L46g6G,6>.>N
– .54B+V34 V6,,65 .543B,3-.+43 *6>4 .>4*3
V+4N9
– $4 .> 653 6/ 4*3 ,6>4 /B30)354 V+)>3>
6/B3K56V*6B6.-.K> .5 *),+5>O lR i 4*3
[6B C353B+< G6G)>3>>.5C >6,3>3B6G6>.KW3
a5-.5C>9
-
8/18/2019 K49 - Retina
34/38
Toxoplasmosis
•
Symptoms –
unilateral, mild ocular pain, blurred vision andnew onset of
floating spots.
• Clinical findings
–
granulomatous iritis, vitritis, optic disc
swelling,neuroretinitis, vasculitis and retinal veinocclusion in
the vicinity of the inflammation, inthe actively involved eye.
–
Funduscopically:
•
active toxoplasmosis presents with white-yellow, choreoretinal
lesions and vitreouscells
•
There may be old, inactive lesions in the
fellow eye
-
8/18/2019 K49 - Retina
35/38
#B3+4,354
•
"B+-.V+43 4*3 G+B+>.43 +5- >)GGB3>> 4*3.5`+,,+46B1
B3>G65>39
• F>.V 4B3+4,354 B3C.,35
–
G1B.,34*+,.53 L+ lR,C 3O /6)N9
– F65V)BB354 /6
-
8/18/2019 K49 - Retina
36/38
#B3+4,354
•
&
• V
-
8/18/2019 K49 - Retina
37/38
Active toxoplasmosis
Inactive toxoplasmosis
-
8/18/2019 K49 - Retina
38/38
23
